XML 69 R57.htm IDEA: XBRL DOCUMENT v3.24.0.1
Summary of Significant Accounting Policies - Summary of Calculation of Basic and Diluted EPS (Parenthetical) (Details) - shares
 2 Months Ended 10 Months Ended 12 Months Ended
Dec. 31, 2021
Oct. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Weighted-average common and potential dilutive common shares outstanding, diluted [1] 20,208 196,591 31,303 30,046
Common Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive securities excluded from the computation of EPS (shares) 0 0    
Potentially dilutive securities excluded from the computation of EPS (shares)   0    
Performance Stock Units (“PSUs”) and Nonvested Restricted Stock Awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Weighted-average common and potential dilutive common shares outstanding, diluted     31,330,597 30,206,521
Antidilutive securities excluded from the computation of EPS (shares)     27,434 160,098
[1] For the Successor year ended December 31, 2023, the computation of diluted EPS does not include contingently issuable shares due to their anti-dilutive nature. Had the contingently issuable shares been dilutive, the denominator for diluted EPS would have been 31,330,597, including 27,434 contingently issuable shares related to unvested restricted stock awards. Due to a net loss for the Successor year ended December 31, 2022, the computation of diluted EPS does not include contingently issuable shares due to their anti-dilutive nature. Had the Successor reported net income for the year ended December 31, 2022, the denominator for diluted EPS would have been 30,206,521, including 160,098 contingently issuable shares related to PSUs and unvested restricted stock awards. There were no potential dilutive common shares and there were no anti-dilutive shares for the Successor period from November 1, 2021 through December 31, 2021. There were no potential dilutive common shares and there were no anti-dilutive shares for the Predecessor period from January 1, 2021 through October 31, 2021.